Effect of a traditional Iranian preparation in oligomenorrhea caused by polycystic ovary syndrome

Formulation and clinical trial of a traditional Iranian based preparation in oligomenorrhea caused by polycystic ovary syndrome (PCOS) in comparison with Dydrogesterone

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201610089618N3

Enrollment

120

Registered

2017-02-15

Start date

2016-08-20

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

polycystic ovary syndrome (PCOS). N95.1 Menopausal and female climacteric states

Interventions

Intervention 1: Intervention group: In this group 60 patients are provided with capsules containing traditional Iranian formulation. This patients are asked to fill the related forms regarding demogr

Treatment - Drugs

Intervention group: In this group 60 patients are provided with capsules containing traditional Iranian formulation. This patients are asked to fill the related forms regarding demographic informati

Control group: In this group 60 patients are provided with capsules containing dydrogesterone. This patients are asked to fill the related forms regarding demographic information and data about thei

Eligibility

Sex/Gender

Female

Age

18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Exclusion criteria: Pregnancy; lactation;abnormal prolactin level; abnormal thyroid hormone level; anatomical position which affects the study; sensitivity to herbal preparations. Inclusion criteria: single ladies; between 18 and 35 years of age; They have BMI between 20 and 30 and they are diagnosed with PCOS by Rotterdam criteria 2013.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Regular menstruation cycle. Timepoint: 2 cycles. Method of measurement: questionnaire.	—

Secondary

Measure	Time frame
BMI. Timepoint: Before the study and at the end of each mensturation cycle for 3 cycles. Method of measurement: questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAyda Hosseinkhani

Research center for traditional medicine and history of medicine

hoseinkhan@sums.a.cir+98 71132337589

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026